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Comparing the Intraoperative Frozen Section With 
Permanent Pathology in Assessing the Depth of Myometrial 
Invasion, Tumor Size, and Histological Subtype and Grade 
in Endometrial Cancer 
Introduction
Endometrial cancer is the most prevalent gynecologic 
malignancy in the world with around 10470 deaths in 
the United States in 2016. In addition, the incidence 
rate of endometrial carcinoma increases by 1%-6% each 
year. Most of the women diagnosed at early stages have 
a rather good prognosis, yet those with advanced or 
recurrent diseases have a poor prognosis (1). International 
Federation of Gynecology and Obstetrics (FIGO) staging 
is an important determinant of the outcomes of patients 
with endometrial cancer. Metastatic status of the lymph 
nodes is the most essential indicator of endometrial 
cancer stage and as such evaluating the status of pelvic 
and para-aortic lymph nodes is important in this respect. 
Therefore, all endometrial cancer patients should undergo 
a total hysterectomy and bilateral salpingo-oophorectomy, 
as well as pelvic and para-aortic lymphadenectomy 
(PLND-PALND). In the case of histological subtype 
criterion endometrioid adenocarcinoma, FIGO grade 1 
and 2, myometrial involvement less than 50%, and tumor 
size smaller than 2 cm, endometrial cancer would be 
considered a low risk (1). In these patients, the disease may 
be treated by the total hysterectomy and bilateral salpingo-
oophorectomy since metastasis to lymph nodes is less 
than 4%. This therapeutic approach has no significant 
effect on the prognosis and therefore, lymphadenectomy 
can be ignored to prevent further morbidity and the 
related costs (2). Only a small proportion of patients with 
low-risk endometrial cancer may benefit from routine 
and comprehensive surgery like the lymphadenectomy. 
However, those with high–risk factors are treated with 
comprehensive staging surgery including PLND-PALND, 
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as well as omentectomy (if needed) without performing 
frozen section (FS) (2). Accordingly, the key question is 
how to identify those endometrial cancer patients who 
may need complete surgical staging.
Using intraoperative FS represents the cornerstone 
of this intermediate strategy since it should identify low 
and high-risk features (3). If FS results suggest high-risk 
attributes such as high grade, deep myometrial invasion, 
tumor size bigger than 2 cm, then full surgical staging is 
conducted (4). However, there are contradictory reports 
on findings related to intraoperative FS and a number of 
researchers consider these results as a valuable guideline 
for intraoperative decision making (4). The limitations 
of the FS approach in endometrial cancer may include 
the need for an expert pathologist, freezing artifacts 
introduced by the FS technique, and time limitation (3).
Since the possibility of lymph node metastasis in lower-
risk tumors is less than 4%, lymphadenectomy may be 
eliminated to prevent morbidity and costs. Otherwise, 
bilateral PLND/PALND must be performed. In this study, 
patients with endometrial cancer undergo comprehensive 
surgical staging such as the total abdominal hysterectomy 
and bilateral salpingo-oophorectomy (TAH + BSO), 
PLND/PALND in the oncology ward of Al-Zahra hospital. 
It is supposed that lymphatic metastasis is low in low-risk 
patients and lymphadenectomy makes no changes in the 
patient’s survival or may even impose mortality upon the 
patient. Accordingly, the findings of this applied research 
can be used to eliminate the lymphadenectomy in low-
risk patients if FS results match the pathology results. 
Therefore, this research sought to evaluate the accuracy 
of FS as a reliable method for intraoperative decision 
making in patients with endometrial endometrioid 
adenocarcinoma.
Accordingly, all of the patients suffering from 
endometrial cancer in Alzahra hospital are subject to 
surgical treatment and systematic lymphadenectomy 
(surgical staging) while if uterus is sent to FS during 
the surgery and signs of low risk factors encompassing 
endometrioid adenocarcinoma, tumor size smaller than 
2 cm, grades 1 and 2, and myometrial involvement less 
than 50% appear, then lymphadenectomy which comes 
along with morbidity can be stopped. This review is 
done in Alzahra hospital by a gynecologic oncologist and 
a pathologist. Accordingly, this review was conducted 
to compare the concordance results of FS with those of 
the permanent pathology. Therefore, in the case there is 
a concordance between these two factors, then it can be 
used by all gynecologic oncologists and pathologists as an 
instruction.
Materials and Methods
The current study was performed during 2016 
(September)-2017 (February) on patients with 
endometrioid adenocarcinoma, detected by diagnostic 
curettage who were admitted for TAH + BSO and surgical 
staging in the oncology ward of Al-Zahra hospital in 
Tabriz. Fifty patients were included in the study, who 
underwent diagnostic curettage before completing the 
surgery and their histology result was endometrioid 
adenocarcinoma, grade1. Non-endometrioid histology, 
tumor grade 3 results, and patients who represented 
extrauter in the spread of tumor by the para clinic and 
intraoperative intra-abdominal and pelvic examination 
were excluded from the study. TAH + BSO surgery and 
uterus bivalve were conducted by a surgeon from the 
cervix to the fundus of the uterine. Then, the tumor size 
was measured by a ruler and the extent of myometrial 
invasion (MI) was estimated by the surgeon accordingly. 
Then, the uterus was sent to the pathology department to 
perform FS and permanent pathology.
Tissue samples were evaluated by FS in terms of 
histological subtype criteria including endometrioid, 
serous, clear cell, undifferentiated, tumor grades 1, 2, and 
3, tumor size smaller or bigger than 2cm, and MI rate 
higher or lower than 50% FS results were compared to the 
final results of paraffin section (PS). The uterus samples 
were measured by FS during the surgeries and low-risk 
symptoms which reduced the chance of metastasis to 
lymph nodes including grade 1, MI less than 50%, tumor 
size smaller than 2 cm, and endometrioid carcinoma were 
identified. FS and permanent pathology results were then 
compared.
Inclusion criteria were patients undergoing a total 
hysterectomy and bilateral salpingo-oophorectomy, 
those with endometrioid adenocarcinoma diagnosis, 
endometrial invasion <50%, tumor size <2 cm by FS 
results, and non-extra-uterine intraoperative macroscopic 
invasion. 
Exclusion criteria encompassed pathology other 
than endometrioid adenocarcinoma and extra-uterine 
involvement.
Finally, the concordance of subtype, grade, tumor size, 
and depth of the MI between FS and the permanent 
section was compared. Data were analyzed using the SPSS 
software, version 17. Further, Cohen (kappa) statistic 
was employed to assess the concordance rate between 
the FS and final pathology with regard to histologic 
subtype, grade, size, and MI. The results were considered 
statistically significant at P < 0.05.
Results
A total of 50 patients with endometrial cancer on either 
endometrial curettage pathology or without evidence 
extrauterus speared of the tumor by the para clinic and 
pelvic exams were analyzed. FS and PS were performed 
on all patients for histological subtype, tumor size, depth 
of MI, and the grade. The concordance rate of histological 
subtype, grade, as well as the size and depth of the MI 
between FS and PS were evaluated in all patients. The 
findings indicated that participants aged between 35 and 
71 years with an average of 55.61 years. Thirty-nine out 
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of 50 patients were positive in PS for the endometrioid 
carcinoma while 11 others were negative in FS for 
endometrioid tumor. Furthermore, 38 out of 50 cases 
were positive in FS whereas 11 patients were negative in 
PS for endometrioid carcinoma. The concordance rate of 
endometrioid subtype between permanent pathology and 
FS is 4%. As represented in Table 1, 45 out of 50 cases are 
negative for undifferentiated in FS, 2 cases are positive 
for undifferentiated in PS and FS, and finally, 48 cases are 
negative for undifferentiated.
Moreover, the concordance rate of undifferentiated 
subtype between permanent pathology and FS is 54.5%. 
Based on Table 1, 45 patients are negative while 4 cases 
are positive for adenosquamous in FS. Finally, 5 cases are 
found positive while the remaining 45 cases are negative 
for adenosquamous in PS.
Additionally, the concordance rate of adenosquamous 
subtype between the permanent pathology and FS was 
39%. 49 out of 50 cases were negative in terms of papillary 
serous in FS and only 1 patient was positive in this regard. 
Eventually, 48 patients were found negative as regards 
papillary serous in PS while 2 cases were detected positive. 
As shown in Table 1, the concordance rate of papillary 
serous subtype between the permanent pathology and FS 
is 66%.
Based on the data in Table 2, considering 50% MI as a 
cutoff, the concordance of the depth of MI is 73% between 
FS and PS. Further, 41 tumors in FS and 41 tumors in PS 
have an MI < 50%. 7 tumors in PS have an MI > 50%.
Tumor size more than 2 cm was considered a risk factor 
for lymph node metastatic while that of less than 2 cm in 
the group is a low risk factor. As shown in Table 2, among 
all 50 cases, 24 tumors are < 2 cm while 26 tumors are > 
2 cm in FS. Furthermore, 25 tumors are <2 cm while the 
remaining 25 tumors are >2 cm in PS. The concordance 
rate of tumor size between FS and PS is 80% (Table 2).
As represented in Table 3, among all the 50 cases, 12 
tumors are grade 1 while 12 tumors are grade 2 in PS and 
FS. In addition, 14 tumors are grade 3 in PS and FS. The 
concordance rate of grade between FS and PS is 64%.
The results of the correlation rate between FS and PS for 
endometrioid subtype had KAPP coefficient (K) value of 
0.492 and was significant at P < 0.001 (Table 1). Moreover, 
the concordance level of myometrium above and below 
50% (MI) had a K value of 0.792 and a P < 0.001 (Table 2). 
As regards the tumor size, the concordance between the 
two methods had a K value of 0.800 and was significant 
at P < 0.001 (Table 2). The K value for the concordance 
rate in tumor grade was 0.641 and it was significant at P 
< 0.001 (Table 3). Additionally, the results regarding the 
undifferentiated indicated that K and significance values 
were 0.545 and < 0.001, respectively (Table 1). Finally, the 
concordance rate for papillary serous demonstrated a K 
value of 0.658 and a significant level of < 0.001 (Table 1).
Discussion 
The main surgical treatment for endometrial cancer is the 
total hysterectomy and bilateral salpingo-oophorectomy 
and surgical staging. In addition, the status of para-aortic 
and pelvic lymph nodes affects both the continuance of 
post-surgery adjuvant treatment and survival (5). Total 
systemic lymphadenectomy during surgical staging is 
approved by most researchers and applicable to high-risk 
patients. However, the role of total lymphadenectomy is 
not clear for the low-risk patients at the early stages of the 
disease (6-10).
In a study, the concordance rate of endometrial cancer 
results between FS and PS methods was 100, 89.3, 
97.3, and 95.5% in terms of histological subtype, grade 
(100/112), MI (109/112), and tumor size (107/112), 
respectively. Further, it was revealed that intraoperative FS 
diagnosis regarding the endometrioid was highly effective 
for surgical staging (2).
Similarly, another research demonstrated that lymph 
nodes metastasis was low in low-risk endometrioid 
cancer and that lymphadenectomy had no beneficial 
Table 1. Concordance Rate Between Permanent Pathology and FS in 
Histologic Subtype Diagnosis
FS Kappa 
Coefficient
P
Yes No
Endometrioid P
Yes 34 5
0.492 <0.001
No 4 7
Undifferentiated P
Yes 2 3
0.545 <0.001
No 45 0
Adenosquamous P
Yes 2 2
0.390 0.005
No 43 3
Papillary serous P
Yes 1 0
0.658 <0.001
No 1 48
Clear cell
Yes 1 1
0.479 <0.001
No 1 47
P, permanent pathology.
Table 2. Concordance Rate Between Permanent Pathology and FS in 
Myometrial Invasion and Tumor Size Diagnosis
Myometrium P Kappa 
Coefficient
P
>50% <50%
Myometrium F
>50% 7 2
0.729 <0.001
<50% 2 39
Tumor size P
≤2 cm >2 cm
Tumor size F
≤2 cm 22 2
0.800 <0.001
>2 cm 3 23
F, Frozen Section; P, permanent pathology.
Table 3. Concordance Rate Between Permanent Pathology and FS in Grade 
Diagnosis
Grade F
Kappa Coefficient P
2 2 3
Grade P
1 12 2 1
0.641 <0.0012 7 12 0
3 0 2 14
P, permanent pathology.
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effect on such patients (11). Furthermore, the results of 
another study indicated that metastasis to lymph nodes 
was 0.8% (12). Therefore, performing lymphadenectomy 
for all endometrioid patients imposes additional costs 
and treatments and increases the rate of mortality. 
Accordingly, using the FS method helps diagnose the 
histological subtype, tumor grade and size, MI, and even 
lymphovascular space involvement. Moreover, FS method 
acts as a guide for diagnosing the metastasis to para-aortic 
and pelvic lymph nodes in high-risk patients and avoids 
performing lymphadenectomy in low-risk patients (13).
The present study was implemented to compare the 
results of the FS with permanent pathology so that to 
determine metastatic factors to pelvic and paraaortic 
lymph nodes. The risk factors included: histological 
subtype, tumor size smaller than 2cm, 1 and 2 grade, and 
myometrial involvement less than 50% (7).
Based on lymphadenectomy during the surgery in the 
early stage, endometrial carcinoma depends on lack of any 
low risk factors. Therefore, focusing on lymphadenectomy 
was highlighted in this study regarding the low risk 
factors. However, a systematic lymphadenectomy vs. lack 
of lymphadenectomy was not intended in the research. 
In the case of endometrioid adenocarcinoma, FIGO 
grade 1, 2, myometrial involvement less than 50%, and 
tumor size smaller than 2 cm, the endometrial cancer 
is considered low risk, and thus lymphadenectomy is 
probably eliminated in this patients (2).
Based on the results of the present study, the concordance 
rate of the risk factors endometrioid, myometrium, tumor 
size, grade, undifferentiated, adenosquamous, pupillary 
serous, and clear cell was 49, 54.5, 39, 65, 64, 73, and 80%, 
respectively. These results suggest that if FS is performed 
accurately and precisely, an appropriate decision can 
be made for the patient’s state. Additionally, the results 
indicated that high concordance rate between FS and final 
pathology belonged to histological subtype (P < 0.001), MI 
(P < 0.001), and grade (P < 0.001), tumor size (P < 0.001).
The results of this study are in line with the results of 
several other published reports, confirming the reliability 
of intra-operative FS in guiding the management 
of early-stage endometrial cancer. The method 
minimizes over-treatment and morbidity while allowing 
gynecologic oncology to select those patients for whom 
lymphadenectomy is a possible therapeutic, prognostic, 
and treatment-planning information (14).
Results of the research conducted on 111 patients 
during (January) 2013-(December) 2014 indicated that 
employing FS for diagnosing the low-risk cases before 
comprehensive staging was highly useful in reducing 
the risk. In addition, the results revealed that there was a 
significant relationship between the histological type and 
invasion depth in PS and FS methods and that FS helped 
the oncologists make the final decision (15).
Further, based on the findings of another research on 
116 patients, an association was found between PS and 
FS results in terms of subtype (97.5%), grade (88%), 
and MI depth (98.2%), respectively. Furthermore, it was 
reported that a total of 7 patients were diagnosed with 
atypical complex hyperplasia in FS method while they 
were diagnosed with cancer in PS and that eventually, two 
patients were not treated completely (14). Research on 
tumor grade suggests that the correlation between the two 
methods is 56%-97% (16-19). Several other studies using 
transvaginal ultrasound highlighted a 58%-95% sensitivity 
in diagnosing MI and a 71%-92% specificity for this 
method (20-25). Moreover, various studies revealed that 
the concordance between PS and FS was 98.7%, 58%-98%, 
and 54%-96.6% regarding histological subtype, grade, and 
MI, respectively (26-31). However, some studies reported 
a poor relationship between PS and Fs methods (27, 28)
The results of the present study are in conformity 
with the related literature, indicating that using the FS 
method for diagnosing the pathological risk factors of 
lymphadenectomy may lead to rather successful treatment. 
The current results demonstrate that FS is an effective and 
appropriate method for treating patients with low-risk 
endometrial cancer. 
Conclusions 
In general, high rates of concordance were found between 
FS and PS respecting histological subtype, MI, as well as 
grade and size of the tumor. This study was conducted in 
gynecology oncology diagnostic center where experienced 
gynecologic pathologists and gynecologic oncology work. 
Therefore, the results may not be generalized to smaller 
diagnostic centers where these specialists do not work. 
Eventually, gynecology oncology diagnostic centers are 
recommended to implement a separate study in order to 
review the accuracy of FS for guiding the intra-operative 
decision regarding lymphadenectomy. 
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